First Business Financial Services Inc. continued to hold its stake in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,495 shares of the pharmacy operator’s stock at the end of the 2nd quarter. First Business Financial Services Inc.’s holdings in CVS Health Corporation were worth $523,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. TB Alternative Assets Ltd. acquired a new position in shares of CVS Health Corporation in the 2nd quarter worth approximately $121,000. Gemmer Asset Management LLC grew its stake in shares of CVS Health Corporation by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after purchasing an additional 200 shares during the last quarter. SRS Capital Advisors Inc. grew its stake in shares of CVS Health Corporation by 48.2% in the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after purchasing an additional 734 shares during the last quarter. Grace & White Inc. NY acquired a new position in shares of CVS Health Corporation in the 2nd quarter worth approximately $199,000. Finally, Nadler Financial Group Inc. acquired a new position in shares of CVS Health Corporation in the 2nd quarter worth approximately $202,000. Hedge funds and other institutional investors own 82.04% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “CVS Health Corporation (CVS) Holdings Held by First Business Financial Services Inc.” was reported by Stock Observer and is the property of of Stock Observer. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at https://www.thestockobserver.com/2017/11/15/cvs-health-corporation-cvs-holdings-held-by-first-business-financial-services-inc.html.
In other CVS Health Corporation news, EVP Thomas M. Moriarty sold 90,267 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $79.61, for a total value of $7,186,155.87. Following the sale, the executive vice president now owns 70,102 shares of the company’s stock, valued at approximately $5,580,820.22. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Thomas M. Moriarty sold 20,547 shares of the business’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the sale, the executive vice president now directly owns 43,178 shares in the company, valued at approximately $3,504,758.26. The disclosure for this sale can be found here. Insiders have sold 714,125 shares of company stock worth $58,119,381 in the last ninety days. 0.61% of the stock is currently owned by insiders.
Shares of CVS Health Corporation (NYSE:CVS) opened at $70.44 on Wednesday. CVS Health Corporation has a one year low of $66.45 and a one year high of $84.72. The firm has a market cap of $72,408.67, a price-to-earnings ratio of 12.52, a PEG ratio of 1.23 and a beta of 0.86. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55.
CVS Health Corporation (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. CVS Health Corporation had a net margin of 2.77% and a return on equity of 16.96%. The business had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. During the same quarter in the previous year, the firm posted $1.64 earnings per share. CVS Health Corporation’s revenue was up 3.5% compared to the same quarter last year. research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, November 3rd. Investors of record on Tuesday, October 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.84%. The ex-dividend date of this dividend was Monday, October 23rd. CVS Health Corporation’s dividend payout ratio (DPR) is currently 41.32%.
CVS has been the topic of several recent research reports. SunTrust Banks, Inc. set a $85.00 price objective on shares of CVS Health Corporation and gave the stock a “buy” rating in a research note on Thursday, October 12th. Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $95.00 target price on shares of CVS Health Corporation in a research report on Monday, October 9th. Mizuho set a $90.00 target price on shares of CVS Health Corporation and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Cowen and Company set a $86.00 target price on shares of CVS Health Corporation and gave the stock a “buy” rating in a research report on Sunday, October 29th. Finally, Needham & Company LLC raised shares of CVS Health Corporation from a “hold” rating to a “buy” rating and lifted their target price for the stock from $69.02 to $79.00 in a research report on Friday, November 10th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $85.82.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.